Please feel free to forward to fellow researchers and share news of our journal | Dear Colleague, We are delighted to announce the publication of Volume 4, Issue 3 of our Kidney Cancer journal. This issue includes one review article looking at how we might better realize the clinical potential of the burgeoning pan-omics data, a brief report comparing trends in first line therapy use for patients with mRCC, and three research articles. View all the open access content via the links below. | Call for Papers As a member of our community, we would like to invite you to submit your own research articles to the journal, which offers contributing authors many benefits: • First class Editorial Board
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press) on acceptance
• The first volumes of the journal freely available to all readers
• Articles accepted this year will be published Open Access with no article processing fee Submit your manuscript online via msTracker
View detailed Instructions to Authors
Aims and Scope Kidney Cancer is an international, multidisciplinary journal that provides an invaluable and indispensable platform for the many collaborative, transdisciplinary, and translational efforts to help treat and finally cure this malignancy. Best wishes, Primo N. Lara Jr, MD
UC Davis Comprehensive Cancer Center
Sacramento, CA, USA
Email: kca@iospress.com Peter Mulders, MD, PhD
Radboud UMC
Nijmegen, The Netherlands
Email: kca@iospress.com Editors-in-Chief
Sign up now for Kidney Cancer news
Join the conversation at: twitter.com/KCA_Journal | All articles are freely available online for all to read, download and share. Review Article The Pan-Omics Landscape of Renal Cell Carcinoma and Its Implication on Future Clinical Practice
Huang, Jennifer J. | Hsieh, James J. Brief Report Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma
Osterman, Chelsea K. | Deal, Allison M. | Milowsky, Matthew I. | Bjurlin, Marc A. | Rose, Tracy L. Research Articles Validation of the Correlation Between Single Nucleotide Polymorphism rs307826 in VEGFR3 and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Sunitinib
Beuselinck, Benoit | Van Brussel, Thomas | Verbiest, Annelies | Vanmechelen, Maxime | Couchy, Gabrielle | Oudard, Stéphane | Elaïdi, Reza | Roussel, Eduard | Albersen, Maarten | et al. Comparing the Responses of Osseous Versus Soft-Tissue Metastases of Renal Cell Carcinoma to Receptor Tyrosine Kinase Inhibitors and Immunotherapy
Tai, Katherine Yuxi | El Abiad, Jad M. | Morris, Carol D. | Markowski, Mark Christopher | Levin, Adam S. Race/Ethnicity and Survival in Metastatic Renal Cell Carcinoma: Outcomes for Patients Receiving First Line Targeted Therapies
Dizman, Nazli | Salgia, Nicholas J. | Bergerot, Paulo G. | Hsu, JoAnn | Ruel, Nora | Pal, Sumanta K. | Most Read Kidney Cancer Articles in August 2020 Listing articles published only in 2019 & 2020 so you can read the most popular recent content Evolving Frontline Treatment Landscape for Advanced or Metastatic Renal Cell Carcinoma (Review Article, Vol.4, Iss.2, 2020)
Jain, Rohit K. | Lara, Primo N. First-Line Immune Checkpoint Inhibitor-Based Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review (Systematic Review in Vol.4, Iss.2, 2020)
Thana, Myuran | Wood, Lori Anne What Comes After Immuno-Oncology Therapy for Kidney Cancer? (Review Article in Vol.3, Iss.2, 2019)
Zahoor, Haris | Duddalwar, Vinay | D’Souza, Anishka | Merseburger, Axel S. | Quinn, David I. Skeletal-Related Events in Patients with Metastatic Renal Cell Carcinoma: A Systematic Review (Systematic Review in Vol.4, Iss.2, 2020)
Jang, Albert | Chen, Shuang R. | Xie, John | Bilen, Mehmet A. | Barata, Pedro C. Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses (Review Article in Vol.3, Iss.1, 2019)
Hahn, Andrew W. | Nussenzveig, Roberto H. | Maughan, Benjamin L. | Agarwal, Neeraj Radiation Therapy for Renal Cell Carcinoma (Review Article in Vol.3, Iss.1, 2019)
Choi, Rachel | Yu, James B. | | Kidney Cancer Association News | Nov 6–7, 2020 | Online The Kidney Cancer Association presents the International Kidney Cancer Symposium (IKCS 2020) as a virtual event taking place on November 6 and 7, 2020. This is an opportunity for physicians, researchers, academics, and industry professionals from across the globe to join together in a virtual setting and exchange ideas which will direct the future of kidney cancer research and treatment in the ultimate pursuit of a cure. The full program covers a wide range of topics, with the Andrew C. Novick Memorial Lecture given by Steven Campbell, MD, PhD, and the keynote entitled “Can Studies of the VHL Gene Get Us to Curative Combination Therapies for Kidney Cancer?” given by William G. Kaelin, Jr., MD – 2019 Nobel Prize recipient in medicine or physiology. The event will also include the IKCS/Virtual Patient Symposium Joint Session on "Treating Kidney Cancer in a Pandemic: Lessons from COVID-19" and there will also be time for virtual posters and networking opportunities. For further information, program details, and registration, visit the event website here. | Please Share Kidney Cancer News With Your Colleagues Help Spread the News! | If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the visual or access the sign-up link here. Kidney Cancer has an active social media presence. If you are not yet interacting with the journal on social media, why not take the time today to follow us on Twitter? Be part of the discussion! | You are receiving this mailing as you are signed up to receive news from KCA.
You can unsubscibe or alter your preferences at any time by clicking the links below. | |
